Indivior (INDV) Projected to Post Earnings on Thursday

Indivior (NASDAQ:INDVGet Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Indivior to post earnings of $0.32 per share and revenue of $259.30 million for the quarter.

Indivior Price Performance

Shares of INDV stock opened at $10.91 on Thursday. Indivior has a 1 year low of $7.33 and a 1 year high of $23.22. The stock’s 50 day simple moving average is $11.56 and its two-hundred day simple moving average is $10.89. The company has a market cap of $1.50 billion, a PE ratio of -272.63 and a beta of 0.73.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Rodman & Renshaw assumed coverage on Indivior in a research report on Tuesday, January 28th. They set a “buy” rating and a $16.00 price objective on the stock. Piper Sandler restated an “overweight” rating and set a $16.00 price objective (up from $15.00) on shares of Indivior in a research report on Friday, October 25th. Finally, RODMAN&RENSHAW upgraded Indivior to a “strong-buy” rating in a research report on Tuesday, January 28th.

Get Our Latest Stock Analysis on INDV

Indivior Company Profile

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Featured Stories

Earnings History for Indivior (NASDAQ:INDV)

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.